EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro Evaluation of the Antimicrobial Activity of Chlorhexidine-Based Shampoos Against Clinical Isolates of Malassezia pachydermatis and Multidrug-Resistant Staphylococcus pseudintermedius

Marcela de Oliveira Platenik, Gianna Goldman iD, Domenico Santoro iD

Microorganisms · 29.07.2026 · 14 (8) · 1660

DOI: 10.3390/microorganisms14081660 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 29.07.2026. Verfasst von Marcela de Oliveira Platenik und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Animal Clinical Sciences, University of Florida College of Veterinary Medicine, Gainesville, FL 32610, USA. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Virbac (France).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Staphylococcus pseudintermedius (SP), including multidrug-resistant SP (MDR-SP), and Malassezia pachydermatis (MP) are major canine cutaneous pathogens. Chlorhexidine-based shampoos, alone or containing azoles, are commonly used in veterinary dermatology; however, comparative data on commercially available products are limited. This study evaluated the in vitro antimicrobial activity of seven chlorhexidine-based shampoos against 30 clinical MDR-SP isolates and 30 clinical MP isolates. Six two-fold dilutions (1:16,000–1:512,000) of KetoChlor®, BioHex®, MAX Chlorhexidine 4%, Douxo S3™ Pyo, TrizCHLOR®4, Malaseb®, and MiconaHex+Triz® were tested using a broth microdilution assay. Minimum inhibitory, bactericidal, and fungicidal concentrations (MIC, MBC, and MFC) were determined. Malaseb® and MiconaHex+Triz® exhibited the lowest MIC and MBC/MFC values, although the observed differences represented a single two-fold dilution step, with MIC values of 1:128,000 against both MDR-SP and MP, and MBC/MFC values of 1:32,000 and 1:128,000, respectively. The remaining shampoos demonstrated bactericidal activity (MIC = 1:32,000/1:64,000; MBC = 1:16,000), while some exhibited MIC and MFC values of 1:64,000 against MP. MIC and MFC endpoints were not reached for a limited number of MP isolates. Overall, all shampoo formulations demonstrated substantial antimicrobial activity across the tested dilution range. Further clinical studies are needed to determine whether these in vitro differences translate into meaningful in vivo efficacy.

Schlagwörter

Stichwörter der Autor:innen

Malassezia pachydermatisStaphylococcus pseudintermediusantimicrobial susceptibilitychlorhexidinetopicals

Autor:innen und Institutionen

  • Department of Small Animal Clinical Sciences, University of Florida College of Veterinary Medicine, Gainesville, FL 32610, USA.
  • Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA 19104, USA.

ORCID-Profile: Gianna Goldman, Domenico Santoro

Förderung

  • Virbac (France)

Zitieren

APA

Platenik, M. O., Goldman, G., & Santoro, D. (2026). In Vitro Evaluation of the Antimicrobial Activity of Chlorhexidine-Based Shampoos Against Clinical Isolates of Malassezia pachydermatis and Multidrug-Resistant Staphylococcus pseudintermedius. Microorganisms, 14(8), 1660. https://doi.org/10.3390/microorganisms14081660

Vancouver

Platenik MO, Goldman G, Santoro D. In Vitro Evaluation of the Antimicrobial Activity of Chlorhexidine-Based Shampoos Against Clinical Isolates of Malassezia pachydermatis and Multidrug-Resistant Staphylococcus pseudintermedius. Microorganisms. 2026;14(8):1660. doi:10.3390/microorganisms14081660

BibTeX
@article{Platenik2026,
  author = {Platenik, Marcela de Oliveira and Goldman, Gianna and Santoro, Domenico},
  title = {In Vitro Evaluation of the Antimicrobial Activity of Chlorhexidine-Based Shampoos Against Clinical Isolates of Malassezia pachydermatis and Multidrug-Resistant Staphylococcus pseudintermedius},
  journal = {Microorganisms},
  year = {2026},
  volume = {14},
  number = {8},
  pages = {1660},
  doi = {10.3390/microorganisms14081660}
}
Kostenlos starten →